Future Science GroupBrowse
Supplementary Table 1.docx (13.52 kB)
Download file

Supplementary Table 1. Nivolumab in Metastatic Renal Cell Carcinoma: Results from the Turkish Oncology Group Kidney Cancer Consortium Database

Download (13.52 kB)
dataset
posted on 2021-11-02, 15:56 authored by Emre Yekedüz, İsmail Ertürk, Deniz Tural, Nuri Karadurmuş, Serdar Karakaya, Mutlu Hızal, Rukiye Arıkan, Çağatay Arslan, Hakan Taban, Ahmet Küçükarda, Nihan Şentürk Öztaş, Özlem Nuray Sever, Gökhan Uçar, Orçun Can, Mehmet Ali Nahit Şendur, Umut Demirci, Saadettin Kılıçkap, İrfan Çiçin, Berna Öksüzoğlu, Mustafa Özgüroğlu, Yüksel Ürün
Supplementary Table 1. Nivolumab in Metastatic Renal Cell Carcinoma: Results from the Turkish Oncology Group Kidney Cancer Consortium Database

Previous Systemic Treatment According to Nivolumab Line

History

Usage metrics

Read the peer-reviewed publication

Nivolumab in Metastatic Renal Cell Carcinoma: Results from the Turkish Oncology Group Kidney Cancer Consortium Database
Future OncologyFuture Oncology

Categories

Keywords

Renal Cell CarcinomaImmunotherapyNivolumabKidney CancerCancer Therapy (excl. Chemotherapy and Radiation Therapy)

Licence

CC BY-NC-ND 4.0

Exports